Nontubercular Mycobacterial Pulmonary Infection in Severe Asthma

To the Editor:
In a recent article in CHEST (January 2011), Fritscher and colleagues 1 identifi ed a group of patients with severe asthma who also had pulmonary infection with nontubercular mycobacterial infection. They suggested that this be considered in older patients with more severe airfl ow obstruction who are on high doses of corticosteroids.
I have a cohort of 84 patients with severe asthma who require daily prednisone to control their eosinophilic bronchitis. The doses of corticosteroids are titrated to maintain sputum eosinophils , 1%. 2 If they have increased total cell count (TCC) and neutrophils (N) in their sputum, they are investigated according to a protocol that includes a detailed microbiologic survey. 3 6 /g; N, 92%). All four patients had intense neutrophilic bronchitis that persisted after the eosinophilic bronchitis was controlled with an optimal dose of corticosteroids. One patient had mild bronchial wall thickening. There were no other causes of airway neutrophilia. The median time from presentation to diagnosis was 5 months. I suggest that, in addition to the clinical criteria suggested by Fritscher and colleagues, persistent sputum neutrophilia should alert physicians to examine for intracellular pathogens such as nontubercular mycobacteria in steroid-dependent asthmatic patients.
